日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effects of novel HDAC inhibitors on urothelial carcinoma cells

新型HDAC抑制剂对尿路上皮癌细胞的影响

Aline Kaletsch, Maria Pinkerneil, Michèle J Hoffmann, Ananda A Jaguva Vasudevan, Chenyin Wang, Finn K Hansen, Constanze Wiek, Helmut Hanenberg, Christoph Gertzen, Holger Gohlke, Matthias U Kassack, Thomas Kurz, Wolfgang A Schulz, Günter Niegisch

Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines

BET 蛋白和 I 类 HDAC 的联合抑制可协同诱导尿路上皮癌细胞系细胞凋亡

Alexander S Hölscher, Wolfgang A Schulz, Maria Pinkerneil, Günter Niegisch, Michèle J Hoffmann

Epigenetic Treatment Options in Urothelial Carcinoma

尿路上皮癌的表观遗传治疗选择

Maria Pinkerneil, Michèle J Hoffmann, Günter Niegisch

Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine

检查点激酶抑制剂 AZD7762 可增强尿路上皮癌细胞对吉西他滨的敏感性

Makoto Isono, Michèle J Hoffmann, Maria Pinkerneil, Akinori Sato, Martin Michaelis, Jindrich Cinatl Jr, Günter Niegisch, Wolfgang A Schulz

Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells

组蛋白乙酰转移酶 GCN5 或 PCAF 敲低对尿路上皮癌细胞的不同影响

Evangelia A Koutsogiannouli, Nicholas Wagner, Christiane Hader, Maria Pinkerneil, Michèle J Hoffmann, Wolfgang A Schulz

Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines

评估新型同种型特异性 HDAC 抑制剂 4SC-202 在尿路上皮癌细胞系中的治疗潜力

Maria Pinkerneil, Michèle J Hoffmann, Hella Kohlhof, Wolfgang A Schulz, Günter Niegisch

The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors

新型永生化尿路上皮细胞系 HBLAK 含有早期尿路上皮肿瘤典型的明确遗传畸变

Michèle J Hoffmann, Evangelia Koutsogiannouli, Margaretha A Skowron, Maria Pinkerneil, Günter Niegisch, Artur Brandt, Stefanie Stepanow, Harald Rieder, Wolfgang A Schulz